2.39
price down icon5.53%   -0.14
after-market Dopo l'orario di chiusura: 2.39
loading

Lantern Pharma Inc Azioni (LTRN) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-09-30 2025-07-01 2025-03-31 2024-12-31 2024-09-30
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
4.3498
- 4.774 5.8964 5.1796
Operating Income/Loss
-4.3498
- -4.774 -5.8964 -5.1796
Income/Loss From Continuing Operations Before Tax
3.55%
-4.1774
-4.331 -4.5368 -5.8752 -4.5057
Income/Loss From Continuing Operations After Tax
3.55%
-4.1774
-4.331 -4.5368 -5.8752 -4.5057
Net Income/Loss
3.55%
-4.1774
-4.331 -4.5368 -5.8752 -4.5057
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
10.83
- 10.78 0.0073 10.76
Diluted Average Shares
10.83
- 10.78 0.0073 10.76
Basic Earnings Per Share
-0.39
- -0.42 -0.54 -0.42
Diluted Earnings Per Share
-0.39
- -0.42 -0.54 -0.42
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Capitalizzazione:     |  Volume (24 ore):